• HSD76 A Real-World Study on Healthcare Resource Utilisation and Patient Care for People With Transthyretin Amyloid Polyneuropathy

    Jul 1, 2025, 00:00

  • PCR100 Interventions to Improve Adherence and Persistence to Oral Medication: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE498 Acute Care Visits and Readmissions Among Medicare Beneficiaries with Heart Failure with Preserved Ejection Fraction (HFpEF) by Obesity Classes

    Jul 1, 2025, 00:00

  • RWD112 Real-World Utilization of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults

    Jul 1, 2025, 00:00

  • PCR49 Exploring the Link Between Self-Efficacy and Medication Adheren Psychometric Evaluation of the Traditional Chinese Beliefs About Medicines Questionnaire-Specific in Adults With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • SA1 Open-Source LLMs Performance on Information Retrieval Tasks for Health Outcomes Research

    Jul 1, 2025, 00:00

  • PCR7 Mapping the GIS to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Gout

    Jul 1, 2025, 00:00

  • EE313 Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China

    Jul 1, 2025, 00:00

  • MSR149 An AI-Powered RAG Based Framework for Data Extractions in Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HPR30 Advancing Real World Eviden Comparative Insights into Global Practices and China's Strategic Progress

    Jul 1, 2025, 00:00

  • HTA6 Real-World Evidence (RWE) in Health Technology Assessment (HTA): Global Guidelines on the Use of RWE in Evidence Generation for HTA Evaluation

    Jul 1, 2025, 00:00

  • PCR142 Utility Over Multiple Health Indexes in Non-Small Cell Lung Cancer: Survey Estimates for Patient-Centered Generalized Risk-Adjusted Cost-Effectiveness (GRACE)

    Jul 1, 2025, 00:00

  • EE439 Double Immune Checkpoint Inhibition as First-Line Treatment for BRAF-Mutant Advanced Melanoma: A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective

    Jul 1, 2025, 00:00

  • PCR11 Clinical Trial Participant and Clinician Experience in a Phase 2 (US-only) Trial of MM120 for Generalized Anxiety Disorder

    Jul 1, 2025, 00:00

  • PCR195 Treatment Preferences in Adults with Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines: Insights from CHOICE-CSU 2 Study

    Jul 1, 2025, 00:00

  • CO15 Exploring the Relationship Between Hemoglobin Levels and Clinical Outcomes in Anemic Dialysis-Dependent Chronic Kidney Disease Patients

    Jul 1, 2025, 00:00

  • EE269 Health Economic Assessment of High-Protein Diet Using High-Protein ONS for Weight Maintenance Following Weight Loss Using GLP-1RAs

    Jul 1, 2025, 00:00

  • PCR37 The Impact of Out-of-Pocket Costs on Adherence Amongst US Oncology Patients on Oral Anticancer Medications

    Jul 1, 2025, 00:00

  • EE520 Evaluating the Budgetary Impact of the Wearable Cardioverter Defibrillator Service for Patients at Risk of Sudden Cardiac Death in the United Kingdom

    Jul 1, 2025, 00:00

  • PCR67 Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling

    Jul 1, 2025, 00:00

  • EE212 Healthcare Resource Utilization Associated With Myotonic Dystrophy Type 1 With Complex Care Needs: Results From the Real-World IMPaCT Study

    Jul 1, 2025, 00:00

  • EPH109 Association of Cognitive Impairment With Benzodiazepine Use in the U.S.: An Analysis of Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • P64 Impact of JCA and Project Orbis on the European Revenue Potential of an Oncology Product

    Jul 1, 2025, 00:00

  • MSR27 Barriers to CAR-T Therapy Access in the U.S.: A County-Level Analysis of Proximity and Sociodemographic Factors

    Jul 1, 2025, 00:00

  • EE220 Impact of Post-Discharge Rifaximin Use Following an Overt Hepatic Encephalopathy (OHE) Hospitalization on Annual Rates of OHE Rehospitalization in the United States

    Jul 1, 2025, 00:00

  • HTA47 Modeling the Path to Cure: How (NEO)Adjuvant Drug Therapies are Evaluated in Health Technology Assessment (HTA)

    Jul 1, 2025, 00:00

  • CO74 Survival Outcomes of Stage IV Endometrial Cancer Patients with Lung Metastasis: A SEER-Based Cohort Study

    Jul 1, 2025, 00:00

  • HTA75 The Effectiveness of an Individualized eHealth Application on Glycemic Control in Diabetes Patients: A Randomized Controlled Trial

    Jul 1, 2025, 00:00

  • PCR240 A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia

    Jul 1, 2025, 00:00

  • EPH184 Metformin Exposure and Survival in Glioblastoma: A Large Population Study

    Jul 1, 2025, 00:00

  • EPH161 A German Claims Database Analysis of Epidemiology, Treatment Patterns, and Healthcare Resource Utilization of Patients with Primary Biliary Cholangitis (PBC)

    Jul 1, 2025, 00:00

  • RWD3 The Relationship Between Weight and Disease Severity in Dogs with Chronic Kidney Disease: Results from a Real-World Study

    Jul 1, 2025, 00:00

  • HPR120 Study on the Impact of the National Drug Price Negotiation Policy on the Affordability of Innovative Drugs in China

    Jul 1, 2025, 00:00

  • CO3 Assessing Time to Metastatic Disease as a Proxy for Overall Survival in a Real-World Pan-Tumor Cohort

    Jul 1, 2025, 00:00

  • MT13 Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective

    Jul 1, 2025, 00:00

  • HPR13 Are Commercial Insurance Premiums Associated With the 340B Drug Pricing Program?

    Jul 1, 2025, 00:00

  • EPH166 Anemia-Related Survival of Patients with Myelofibrosis: A Retrospective Real-World Study

    Jul 1, 2025, 00:00

  • PCR26 Defining Unmet Need to Optimize Management of Adults and Adolescents With Psoriasis: Development of a Global Multistakeholder Survey

    Jul 1, 2025, 00:00

  • HPR160 Relationships Between ICER Clinical Evidence Ratings and FDA Approval Decisions

    Jul 1, 2025, 00:00

  • HPR156 The Inflation Reduction Act: Evaluating Impact on Medicare Drug Pricing, Innovation, and Access to Therapies

    Jul 1, 2025, 00:00

  • RWD17 Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)

    Jul 1, 2025, 00:00

  • MSR44 Going Beyond Excel vs. R: An Introduction To Visual Programming for Health Economics Modelling

    Jul 1, 2025, 00:00

  • CO60 Relationship between Genetic Polymorphisms and Clinical Parameters in Mexican Postmenopausal Women: A Study on Cardiovascular Health

    Jul 1, 2025, 00:00

  • PT39 Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada

    Jul 1, 2025, 00:00

  • EPH79 Assessing Adolescent Mental Health Prevalence and Incidence Pre- and Post-COVID-19 Among Texas Medicaid Recipients

    Jul 1, 2025, 00:00

  • MSR41 The Use of Large Language Models for Systematic Literature Review Automation: An Evaluation of Quality and Time Savings

    Jul 1, 2025, 00:00

  • First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • RWD47 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia

    Jul 1, 2025, 00:00

  • PCR105 The Impact of Caring for Juvenile Idiopathic Arthritis Patients on Caregivers’ Quality of Life

    Jul 1, 2025, 00:00

  • EPH141 Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age

    Jul 1, 2025, 00:00

  • EE203 Comparing Ex-Vivo and In-Vivo Administration in CRISPR-Based Gene Therapies for Beta-Thalassemia: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • EE466 Budget Impact Analysis of the Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for disease prevention among Colombian Infants

    Jul 1, 2025, 00:00

  • EPH55 Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil

    Jul 1, 2025, 00:00

  • MSR95 Sizing Up the Gap: Evaluating Sample Size Justification in Prospective Real-World Studies

    Jul 1, 2025, 00:00

  • SA12 Incidence, Prevalence, and Risk Factors of Giant Cell Arteritis: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • OP10 The Impact of Research Sessions on Pharmacy Students’ Perceived Understanding in Research Design and Methodology

    Jul 1, 2025, 00:00

  • MSR120 Estimating Sample Size for Training Ensemble Machine Learning Models

    Jul 1, 2025, 00:00

  • MSR56 Comparison of AI-Enhanced Tools for Automating Scientific Literature Reviews

    Jul 1, 2025, 00:00

  • MSR101 Evaluating Pain Scores and Detecting NSCLC Using Named Entity Recognition and Agentic AI in Clinical Texts

    Jul 1, 2025, 00:00

  • MSR145 Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?

    Jul 1, 2025, 00:00

  • RWD108 A1c Improvement After Initiating Real-Time Continuous Glucose Monitoring Among People with Type 2 Diabetes Not on Insulin Therapy

    Jul 1, 2025, 00:00

  • PCR191 Impact Of Valbenazine On Improvements In Health-Related Quality of Life (HRQoL) In Patients With Tardive Dyskinesia (TD): EQ-5D-5L Results From A Phase 4 Randomized Withdrawal Study (NCT03891862)

    Jul 1, 2025, 00:00

  • HTA3 The Institute for Clinical and Economic Review and Joint Clinical Assessment: Insights for Manufacturers in an Evolving Health Technology Assessment Landscape

    Jul 1, 2025, 00:00

  • HTA66 Cost-Effectiveness of Intravenous Ferric Carboxy Maltose Versus Iron Sucrose to Treat Anemia in Pregnancy in Indian Context

    Jul 1, 2025, 00:00

  • MT4 Exploring Mobile and Wearable Technology for Early Depression Detection and Monitoring

    Jul 1, 2025, 00:00

  • EE445 Risk of Hospital Readmission Among Adults Aged 50 Years and Older Hospitalized With Respiratory Syncytial Virus (RSV) or Influenza

    Jul 1, 2025, 00:00

  • PCR155 Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States

    Jul 1, 2025, 00:00

  • MSR83 Early Detection of CHAPLE Disease in Pediatric Protein-Losing Enteropathy: A Feasibility Study

    Jul 1, 2025, 00:00

  • RWD160 Optimizing Adherence to Intravenous Iron: A Geographic Analysis of Variability Within the United States

    Jul 1, 2025, 00:00

  • P41 Incorporating External Opinion in Survival Extrapolations to Inform Long-Term Survival Projections for Health Technology Assessment

    Jul 1, 2025, 00:00

  • MSR1 Predictive Modeling for Designing a Personalized Statin Therapy: Optimizing Treatment Efficacy in Cardiovascular Disease Prevention

    Jul 1, 2025, 00:00

  • PCR206 Incorporating Best-Worst Scaling into Attribute Selection for Stated Preference Research: A Study Based on Preference for Choosing Antidepressants

    Jul 1, 2025, 00:00

  • PCR74 Utility of Mobile Health Applications, Wearable Devices, and Patient Generated Health Data in Menopause Research

    Jul 1, 2025, 00:00

  • EE311 The Equitable Quality-Adjusted Life-Year

    Jul 1, 2025, 00:00

  • PCR135 Disparities in COVID-19 Vaccination Uptake by Social Vulnerability Index: A US nationwide study

    Jul 1, 2025, 00:00

  • HSD18 Variation in Recombinant Zoster Vaccine Uptake and Completion by Utilization of Office-Based Vaccination

    Jul 1, 2025, 00:00

  • P45 Is There Any difference in Preferences Between Patients and Physicians? Evidence From Anti-Hyperglycemic Medications Choices for Type 2 Diabetes

    Jul 1, 2025, 00:00

  • EE429 Economic Burden of HER2+ Breast Cancer and the Targeted Therapies Epidemiological Economic Impact in Trinidad and Tobago

    Jul 1, 2025, 00:00

  • PCR165 Qualitative Interviews to Characterize Disease and Treatment Burden at Baseline in Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for the Treatment of Glycogen Storage Disease Type Ia

    Jul 1, 2025, 00:00

  • HPR79 Unlocking AI's Potential in Pricing and Reimbursement: Insights Across Global Healthcare Archetypes

    Jul 1, 2025, 00:00

  • HSD66 Environmental Impact of Digital Remote Care Versus Standard Care for CML Patients

    Jul 1, 2025, 00:00

  • RWD36 Accelerating EHR Insights: NLP-Driven Data Abstraction in Gallbladder Cancer

    Jul 1, 2025, 00:00

  • CO36 Impact of Procedure Wait Times on One-Year Health Outcomes in Patients With Degenerative Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

    Jul 1, 2025, 00:00

  • EPH106 Trend of Cervical Cancer Mortality in Colombia From 1998 to 2022

    Jul 1, 2025, 00:00

  • HPR4 Evolving HTA and Potential EU HTAR Ripple Effects in the US: Insights From a Stakeholder Survey

    Jul 1, 2025, 00:00

  • EE326 A Cost Per Responder Analysis of Ritlecitinib and Baricitinib: Assessing the Impact of Clinical Efficacy and Dosing Variability on Overall Treatment Costs of Severe Alopecia Areata (AA)

    Jul 1, 2025, 00:00

  • RWD46 Operational Definitions in Practi Finding and Evaluating Algorithms for Identifying Patients with Cervical and Uterine Cancer for Real World Data Studies

    Jul 1, 2025, 00:00

  • PT30 Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023

    Jul 1, 2025, 00:00

  • RWD155 Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States

    Jul 1, 2025, 00:00

  • PT28 Evaluation of Measurement Properties of Health Assessment Questionnaire Disability Index (HAQ-DI) among Gout Populations in China

    Jul 1, 2025, 00:00

  • P58 A Bayesian State-Transition Model-Based Approach to Estimate Transition Rates From Aggregated Survival Data

    Jul 1, 2025, 00:00

  • MSR63 Extraction of Pulmonary Function Test Results from Unstructured Clinical Notes using a Retrieval-Augmented Generation Approach on a Major Cloud Platform

    Jul 1, 2025, 00:00

  • HSD105 Development and Validation of a Machine Learning-Based Prediction Model for 30-Day COPD Readmissions: Enhancing Early Risk Stratification and Intervention

    Jul 1, 2025, 00:00

  • SA8 A Comparison of Single-Network and Multi-Site Approaches to Real-World Data Collection

    Jul 1, 2025, 00:00

  • PCR171 Examining Health Behaviour of Inviduals Diagnosed With Polycystic Ovary Syndrome

    Jul 1, 2025, 00:00

  • EPH120 Clinical Characteristics and Healthcare Resource Utilization Among Patients Initiating Semaglutide 2.4mg Versus Those Not Treated With Anti-Obesity Medications

    Jul 1, 2025, 00:00

  • EE301 Cost-effectiveness Analysis of Zavegepant in Acute Migraine Treatment

    Jul 1, 2025, 00:00

  • HTA40 The Role of Real-World Evidence in Addressing Gaps in Health Technology Assessment in Brazil’s Public Healthcare System

    Jul 1, 2025, 00:00

  • PCR259 Information-Seeking Behavior of the Hungarian Population Regarding Breast Cancer: A Digital Epidemiological Study using Google TrendsTM

    Jul 1, 2025, 00:00

  • HPR29 Evaluating Therapeutic Alternative Selection in Medicare's Initial Drug Price Negotiation Explanations

    Jul 1, 2025, 00:00

  • HSD63 Perspectives on Real-World Management of Stomatitis/Oral Mucositis (S/OM) From Oncologists With Experience Treating Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • RWD21 Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic Triple Negative Breast Cancer (mTNBC)

    Jul 1, 2025, 00:00

  • EE518 Impact of Information Technology Enhancement for Human Papillomavirus Vaccination: Time and Cost Savings

    Jul 1, 2025, 00:00

  • EE274 Epidemiological Analysis and Patient Profile of Lung Cancer in the Brazilian Public Health System: A Real-World Data Study

    Jul 1, 2025, 00:00

  • RWD121 Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study

    Jul 1, 2025, 00:00

  • PCR70 The Impact of Information and Under-Information on Quality of Life in People With Polycystic Ovary Syndrome

    Jul 1, 2025, 00:00

  • PCR174 Facilitating Effective Implementation of Qualitative in Trial Interviews

    Jul 1, 2025, 00:00

  • EPH58 Evaluating the Cost-Effectiveness of Wastewater-Based Disease Surveillance

    Jul 1, 2025, 00:00

  • CO89 Persistence of Infliximab Biosimilar versus Originator in Patients with Crohn's Disease: a Retrospective Cohort Study in China

    Jul 1, 2025, 00:00

  • HPR19 Racial Disparity in Healthcare Expenditure Among Older Adults with Cardiovascular Diseases

    Jul 1, 2025, 00:00

  • PCR43 Challenges and Opportunities for the Use of Patient Experience Data in Gene Therapy Trials

    Jul 1, 2025, 00:00

  • PCR68 Perceived Health Status among Patients with Norovirus and Acute Gastroenteritis

    Jul 1, 2025, 00:00

  • MSR70 Using Machine Learning to Estimate Perceptions and Future Prescribing Intentions of Health Care Providers: A Novel Application of Integrated Primary and Secondary Data in Understanding HCP Decision-Making

    Jul 1, 2025, 00:00

  • HTA41 Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs

    Jul 1, 2025, 00:00

  • HPR11 Diversity, Equity, and Inclusion in Gene and Cell Therapies Clinical Trials

    Jul 1, 2025, 00:00

  • CO92 Understanding Predictors of Early-Onset Colorectal Cancer in Personal Health Data with Machine Learning

    Jul 1, 2025, 00:00

  • PT7 Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival

    Jul 1, 2025, 00:00

  • HPR152 Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • HTA21 Integrating Cancer Trials Into Value-Based Care: The ‘Let Me Trial’ Model in Brazil

    Jul 1, 2025, 00:00

  • EE395 The Annual Economic Burden of RSV in High-Risk US Adults Aged 18-59: A Modeling Study

    Jul 1, 2025, 00:00

  • EPH4 All for One and One for All? Patterns of Familial Influenza Vaccination

    Jul 1, 2025, 00:00

  • EE312 Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population

    Jul 1, 2025, 00:00

  • PCR132 Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents

    Jul 1, 2025, 00:00

  • PCR168 Assessing the Validity of the SF-36 Health Survey Among Chinese Individuals with Spinal Cord Injuries

    Jul 1, 2025, 00:00

  • HSD30 Characterization of Patients With Desmoid Tumors (DT) and Their Treatment Patterns Within an Academic Health System in the United States

    Jul 1, 2025, 00:00

  • PCR145 Health-Related Quality of Life and Productivity Losses Across Stages of Breast and Colorectal Cancer

    Jul 1, 2025, 00:00

  • EPH185 Linkage Of Patient Services and Real-world Healthcare Data: A Unique Approach to Gain Insights into Factors that Impact Medication Adherence

    Jul 1, 2025, 00:00

  • EE221 How to Mitigate "Carer QALY Trap” when Including Caregiver QOL in Cost-Effectiveness Analysis: A Model Simulation Using Lecanemab in Japanese Patients with Alzheimer's Disease

    Jul 1, 2025, 00:00

  • HPR165 Application of England's Severity Weighting to Cost-Effectiveness Evaluations in Japan

    Jul 1, 2025, 00:00

  • Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • EE383 Pharmacometric-Pharmacoeconomic Modeling and Simulation to Assess Target Product Profile Characteristics in Early Drug Development: Application to Atopic Dermatitis

    Jul 1, 2025, 00:00

  • HSD97 Market Access as Defined by Professionals with Market Access Backgrounds - Scoping Review

    Jul 1, 2025, 00:00

  • EPH63 Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study

    Jul 1, 2025, 00:00

  • PCR221 Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • EPH145 Shades of Blue: Investigating Racial, Socioeconomic, and Family Dynamics in Depression Among Teen Girls

    Jul 1, 2025, 00:00

  • MSR150 Validity and Accuracy of Asthma-Related ICD-10 Diagnosis Codes in United States Real-World Administrative Database

    Jul 1, 2025, 00:00

  • Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy

    Jul 1, 2025, 00:00

  • RWD120 Comparison of Demographics and Clinical Characteristics Using Real World Data from Tempus Multimodal Database and SEER Cancer Registry Across 17 Solid Cancer Cohorts

    Jul 1, 2025, 00:00

  • SA3 Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis

    Jul 1, 2025, 00:00

  • PCR96 Sociodemographic Variations in Perceived Social Support Among Adults with Depression in the United States: Results From the National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • HTA54 Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan

    Jul 1, 2025, 00:00

  • CO69 Combining Patient Clustering and Quantitative Benefit-Risk Assessment in the Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention

    Jul 1, 2025, 00:00

  • RWD125 Retrospective Real-World Study Assessing Treatment Patterns of Adult Patients with Moderate-to-Severe Psoriasis in the United States Initiating Advanced Therapies and Their Dispositions

    Jul 1, 2025, 00:00

  • MT31 Adoption of a Drug Adherence-Enhancing Application To Achieve Optimal Medication Adherence and Blood Pressure Control Among Hypertensive Patients: A Randomized Controlled Trial

    Jul 1, 2025, 00:00

  • EPH132 Administrative Frequency of Alopecia Areata and Clinical Characteristics in a Colombian HMO: a Real-World Data Characterization For 2015-2023

    Jul 1, 2025, 00:00

  • EE357 Cost-Effectiveness Analysis of Technosphere Insulin (TI) Versus Insulin Aspart Injection in Type 1 Diabetes Management: Perspective From the US Healthcare System

    Jul 1, 2025, 00:00

  • MSR109 Artificial Intelligence Integration in Health Technology Assessments: A Review of Global Policies and Practices

    Jul 1, 2025, 00:00

  • HPR78 Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis

    Jul 1, 2025, 00:00

  • MT42 Bench Study Assessing the Impact of the Next Generation of Vitreoretinal-Cataract System on System Set-Up and Tear-Down Time for Vitreoretinal Surgery

    Jul 1, 2025, 00:00

  • RWD54 Characteristics of Adults With Type 2 Diabetes Who Are Not Treated With A Glucose-Lowering Agent: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • EE373 Utilization of Adalimumab and Infliximab Biologics and Biosimilars in Rheumatoid Arthritis Patients

    Jul 1, 2025, 00:00

  • HPR18 Real-world Impact of the United States Preventive Services Task Force (USPSTF) Guidelines on HIV-1 Pre-Exposure Prophylaxis (PrEP) Ancillary Service Cost Sharing: Segmented Change Pre- and Post-Milestone USPSTF Timepoints

    Jul 1, 2025, 00:00

  • P40 Cost-Effectiveness Analysis of Second-Generation Antipsychotic Long-Acting Injectables in Patients with Schizophrenia in the United States

    Jul 1, 2025, 00:00

  • HSD11 Treatment Patterns in the Management of Vitiligo in a Colombian HMO During 2015-2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • EE464 Economic and Healthcare Burden in Patients with Sjögren's Syndrome: A Systematic Review

    Jul 1, 2025, 00:00

  • PCR120 Experiences of Hungarian Mothers About Breastfeeding Support From Health Visitors

    Jul 1, 2025, 00:00

  • MSR47 Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective

    Jul 1, 2025, 00:00

  • PCR246 Preferences for Parkinson's Disease Treatments: A Scoping Literature Review

    Jul 1, 2025, 00:00

  • SA2 Assessing the Feasibility of Indirect Comparisons of Vaccines: A Framework for Network Meta-Analysis

    Jul 1, 2025, 00:00

  • RWD33 Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017-2023)

    Jul 1, 2025, 00:00

  • HPR128 Cost of Vaccine Misinformation on the US Healthcare System

    Jul 1, 2025, 00:00

  • EE367 A Framework for Evaluating the Economic and Operational Impact of Adopting the Sentimag®platform for Lesion Localization and Sentinel Lymph Node Biopsy in Women with Breast Cancer

    Jul 1, 2025, 00:00

  • EE454 Economics of Prostate Cancer in Canada: A Systematic Review

    Jul 1, 2025, 00:00

  • CO4 Systematic Evaluation of Bone Health Dynamics Associated With GLP-1 Receptor Agonists in Type 2 Diabetes Patients: Fracture Risk and Osteoporotic Complications

    Jul 1, 2025, 00:00

  • OP4 Perception Gap Between Preceptors and Pharmacy Students on Clinical Pharmacy Practice Education (CPPE) in Hospital Pharmacy

    Jul 1, 2025, 00:00

  • MSR22 Evaluating the Application of GPT-4o and Retrieval-Augmented Generation (RAG) for Assessing Risk of Bias and Study Quality in Systematic Literature Reviews (SLRs): Preliminary Findings from a Comparative Study

    Jul 1, 2025, 00:00

  • EPH97 Overall Survival in People Living with HIV, Who Experienced Progressive Multifocal Leukoencephalopathy

    Jul 1, 2025, 00:00

  • R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior Code

    Jul 1, 2025, 00:00

  • PCR255 Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value

    Jul 1, 2025, 00:00

  • EPH49 Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or Prevention

    Jul 1, 2025, 00:00

  • HSD107 Individualized Electronic Patient Reported Outcome Measures as a Communication Aid in Outpatient Cardiology Care

    Jul 1, 2025, 00:00

  • HSD95 Development of a Tool for Population Health Risk Stratification in Primary Care Through Consensus-Seeking Techniques

    Jul 1, 2025, 00:00

  • RWD118 Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)

    Jul 1, 2025, 00:00

  • HPR148 Payer Survey Uncovers Likely Increased Management Strategies Following Release of Initial 10 Drugs Selected for Price Negotiation

    Jul 1, 2025, 00:00

  • CO33 Comparison of Suicidal Ideation or Personal History of Self Harm Among Patients with Use of Rexulti and All Antipsychotics

    Jul 1, 2025, 00:00

  • PCR161 Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE238 Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data

    Jul 1, 2025, 00:00

  • P19 Advancing Equity in CAR T-Cell Therapy: An Analysis of Health Technology Assessments by Canada's Drug Agency and the National Institute for Health and Care Excellence

    Jul 1, 2025, 00:00

  • Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Working Group Report

    Jul 1, 2025, 00:00

  • PCR229 Increasing Clinical Trial Participation in Native Hawaiian, Pacific Islander, and Asian Communities

    Jul 1, 2025, 00:00

  • PCR204 Over 30 Years of Discrete Choice Experiment Studies in Health Economics: Systematic Review of Current Practice and Reflections on Evolving Practice

    Jul 1, 2025, 00:00

  • PCR256 Patient Perspectives on Communication With Clinicians: A Survey on Hospitalized Patient Experiences

    Jul 1, 2025, 00:00

  • HPR103 Comparing Medicare Maximum Fair Prices with Other Drug Prices in Other Countries

    Jul 1, 2025, 00:00

  • EE226 Household Costs and Other Societal Impacts for Individuals With Duchenne Muscular Dystrophy Stratified by Upper Limb Impairment: Results From a Caregiver Survey

    Jul 1, 2025, 00:00

  • EE407 The Cost-effectiveness Analysis of Gene Therapy for Severe Hemophilia B Patients in China: A Microsimulation Experiment Study

    Jul 1, 2025, 00:00

  • HSD41 Impact of Racial and Ethnic Disparities on Health-Related Quality of Life in Older Adults With Arthritis in the United States

    Jul 1, 2025, 00:00

  • PCR32 Informal Caregivers' Attitudes Towards Robots in Hungary and Poland

    Jul 1, 2025, 00:00

  • EE336 A Conceptual Epidemiological and Economic Model to Predict Obesity in Low- and Middle-Income Countries: A Meta-Synthesis

    Jul 1, 2025, 00:00

  • P15 Boosting Predictive Power: Thoughtfully Unleashing the Potential of Machine Learning In Real-World Healthcare Outcome Estimation

    Jul 1, 2025, 00:00

  • HPR118 The Role of Invasive Diagnostics in Prior Authorization for MASH

    Jul 1, 2025, 00:00

  • RWD139 Burden Of Hidradenitis Suppurativa In The Brazilian Private Healthcare System

    Jul 1, 2025, 00:00

  • MSR66 Developing a Risk Prediction Model for the Identification of Necrotizing Fasciitis (NF) in Patients

    Jul 1, 2025, 00:00

  • CO73 Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (7.5mg) across 1.5 Years

    Jul 1, 2025, 00:00

  • MT36 Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • EPH188 Economic Modelling of Myopia Management: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • RWD77 Patterns in Provider Specialties and Adoption of Non-Invasive Tests (NITs) for Diagnosing Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Jul 1, 2025, 00:00

  • HSD52 Understanding Barriers to the Early Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease from the Perspective of Physicians and Patients: Results from a Real-World Survey in Germany

    Jul 1, 2025, 00:00

  • HPR157 Evaluating the Effect of Type of Insurance Coverage on Changes in Prescription Medication Utilization During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • HSD113 Characterization of the Trajectories of Care Post-Liver Transplant Recipients From Virginia Using Real World Data

    Jul 1, 2025, 00:00

  • RWD23 Unlocking the Potential of Radiology Reports Using NLP: A Real-World Data Approach to Rotator Cuff Tear Severity

    Jul 1, 2025, 00:00

  • HSD27 Choosing Wisely?' Use of Staging Imaging in US Veteran Patients With Prostate Cancer

    Jul 1, 2025, 00:00

  • RWD152 Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • HSD8 A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England

    Jul 1, 2025, 00:00

  • CO20 Real-World Overall Survival of Multiple Myeloma Patients in a Colombian HMO During 2015-2023

    Jul 1, 2025, 00:00

  • EE369 Healthcare Resource Utilization (HCRU), Costs, and Outcomes Among Patients With Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) in the United States: A Retrospective, Real-World Analysis of Administrative Claims Data

    Jul 1, 2025, 00:00

  • MSR142 Performance Assessment and Validation of Real-World Response Data Generated Using a Deep Learning-Based Natural Language Processing Model Across Multiple Solid Tumors

    Jul 1, 2025, 00:00

  • EPH125 Validation of ICD Code-Based Identification of Myocarditis Among mRNA COVID Vaccine Immunized Patients and COVID-Infected Patients

    Jul 1, 2025, 00:00

  • EE505 Economic Evaluation of Next-Generation Sequencing Technologies in Paediatric Patient Groups With Rare Diseases: a Systematic Review

    Jul 1, 2025, 00:00

  • EPH71 Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)

    Jul 1, 2025, 00:00

  • HTA97 Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis

    Jul 1, 2025, 00:00

  • MSR110 From Manual to Machine: A Deep Dive into AI-Powered Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HPR2 Mapping Disparities in Clinical Trial Enrollment Among HCC Patients: Insights From Social Determinants of Health

    Jul 1, 2025, 00:00

  • PCR55 Parental Self-Efficacy in the Management of Pediatric Type 1 Diabetes Mellitus: A Subgroup Analysis Among CGM Sensor Users

    Jul 1, 2025, 00:00

  • EE508 Abnormal Uterine Bleeding in Brazil: Comparison of 52mg LNG-IUS and Histerectomy

    Jul 1, 2025, 00:00

  • P47 Patient Preferences on Understanding Medical Tests and Monitoring Equipment in Hospitalized Care

    Jul 1, 2025, 00:00

  • EE497 Cost-Effectiveness of Robot-Assisted and Laparoscopic Radical Nephrectomy Versus Open Radical Nephrectomy in the Treatment of Renal Cell Carcinoma

    Jul 1, 2025, 00:00

  • HPR133 Coverage Gaps: Do U.S. Commercial Health Plans Have Concordant Alzheimer's Disease Therapy Testing Policies?

    Jul 1, 2025, 00:00

  • EE262 Epidemiological and Economic Analysis of Hospitalizations for Cellulitis and Erysipelas From the Perspective of a Brazilian Health Insurance Company

    Jul 1, 2025, 00:00

  • HSD73 Real-World Primary Care Data on Menopause: Insights into Diagnoses, Treatment Patterns, and Care Gaps

    Jul 1, 2025, 00:00

  • EE282 Quality-Adjusted Life Year (QALY) Results From a Cost-Effectiveness Model for Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Relapsed/Refractory Multiple Myeloma (RRMM)

    Jul 1, 2025, 00:00

  • RWD83 Variation in Provider Reimbursement for Biosimilars and Reference Biologics by Commercial Health Plans

    Jul 1, 2025, 00:00

  • EE353 Cost-Effectiveness Analysis of Regorafenib Versus FTD-TPI + Bevacizumab in Patients with Metastatic Colorectal Cancer from the Perspective of the Brazilian Supplementary Health System

    Jul 1, 2025, 00:00

  • HSD38 Insights into Ophthalmology Workforce Dynamics and Procedural Trends: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE514 Disease Burden Estimates in Economic Evaluation Studies of Respiratory Syncytial Virus (RSV) Maternal Immunization: A Systematic Review

    Jul 1, 2025, 00:00

  • EE386 Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada

    Jul 1, 2025, 00:00

  • MSR16 AI-Driven Evidence Synthesis: Leveraging RAG and Multi-Agentic Approach to Conduct Disease Landscape Assessments

    Jul 1, 2025, 00:00

  • EE496 Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management

    Jul 1, 2025, 00:00

  • MT1 Value of Personalized Refractive Procedure: A Survey of Perceived Clinical Outcomes, Practice Benefits, and Patient Satisfaction in China

    Jul 1, 2025, 00:00

  • MSR147 Evaluating Imaging Artificial Intelligence (AI) Matching Real-World Digital Twins (rwDTs) Into an External Control Arm (ECA) for MYSTIC: A Phase 3 Clinical Trial in Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • EE264 Number Needed to Treat and Associated Costs Per Additional Responder of Biologic Therapies in Adult Patients With Moderate To Severe Atopic Dermatitis

    Jul 1, 2025, 00:00

  • PCR75 Adverse Events: Does Experience Impact Preferences? A Review of the Literature

    Jul 1, 2025, 00:00

  • RWD67 Analysis of Disease Progression in 769 Patients With Dominant Alport Syndrome

    Jul 1, 2025, 00:00

  • EE377 What is the Role of Humans in a World of Artificial Intelligen An Exploratory Economic Evaluation of Human-AI Collaboration in Diabetic Retinopathy Screening

    Jul 1, 2025, 00:00

  • HTA93 Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure

    Jul 1, 2025, 00:00

  • PT41 Structured Evaluation of Oncology Real-World Data Quality for Practical Applications

    Jul 1, 2025, 00:00

  • CO9 Exploring Patient Perspectives of Statistically Derived Item Weights for Composite Scores in Spinocerebellar Ataxia

    Jul 1, 2025, 00:00

  • RWD105 Benchmarking Disease Prevalence in a Large Scale Electronic Health Record Data Network: An Assessment of Chronic and Rare Disease in the United States in 2023

    Jul 1, 2025, 00:00

  • MSR151 Group-Based Trajectory Modeling to Identify Longitudinal Patterns of Adherence to Statins in Older Adults on Concomitant Triple Therapy (Oral Antidiabetic, RAS Antagonists, Statins)

    Jul 1, 2025, 00:00

  • CO48 Analyzing the Association Between Statin Use and New Onset Diabetes in the US: A Retrospective Analysis Using Integrated EHR and Claims Data

    Jul 1, 2025, 00:00

  • PCR51 Information-Seeking Behavior of the Hungarian Population Regarding Lung Cancer: A Digital Epidemiological Study Using Google Trends™

    Jul 1, 2025, 00:00

  • HPR74 Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade

    Jul 1, 2025, 00:00

  • EPH177 Advancing Health Economics: Incorporating AMR Impact Into Pneumococcal Vaccine Assessment

    Jul 1, 2025, 00:00

  • EE350 Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada

    Jul 1, 2025, 00:00

  • MSR111 Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HPR109 Impact of Increased Patients' Out-of-Pocket Costs on Oral Anticoagulant Discontinuation among Medicare Beneficiaries with Atrial Fibrillation Treated with Apixaban

    Jul 1, 2025, 00:00

  • EE329 Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024

    Jul 1, 2025, 00:00

  • HSD47 Increase in Healthcare Professionals' Willingness to Counsel HPV Vaccine Hesitant Parents Post-Pandemic: Results from a National Survey

    Jul 1, 2025, 00:00

  • PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

    Jul 1, 2025, 00:00

  • EE306 Healthcare Resource Utilization of Tafamidis Patients in the United States

    Jul 1, 2025, 00:00

  • PCR196 Hypophosphatasia (HPP) Patient Treatment Experien A Mixed Methods Study Concept

    Jul 1, 2025, 00:00

  • MT35 Race and Ethnicity Differences in the HPV Vaccine Initiation Prompted by Electronic Reminders

    Jul 1, 2025, 00:00

  • MSR85 Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders

    Jul 1, 2025, 00:00

  • EE402 Cost-Effectiveness Analysis of Eladocagene Exuparvovec-tneq for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) and Comparison with Other Rare Disease One-Time Treatments in the United States

    Jul 1, 2025, 00:00

  • RWD116 Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction

    Jul 1, 2025, 00:00

  • EPH69 Racial and Ethnic Disparities in Healthcare Expenditures Among United States Older Adults with Joint Pain

    Jul 1, 2025, 00:00

  • PCR162 Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil

    Jul 1, 2025, 00:00

  • PCR157 Estimated Impact of Pre-Exposure Prophylaxis for COVID-19 on Quality of Life and Physical Distancing Among Immunocompromised Individuals and Caregivers

    Jul 1, 2025, 00:00

  • EE384 Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study

    Jul 1, 2025, 00:00

  • MT14 Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR38 Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)

    Jul 1, 2025, 00:00

  • MSR122 MetaSLR: AI-Driven Screening and Extraction Platform with Integrated Quality Assurance Checkpoints

    Jul 1, 2025, 00:00

  • EPH39 Estimating the Prevalence of Chronic Conditions in Population Health Management

    Jul 1, 2025, 00:00

  • EE473 Cost-Efficiency Modeling of Conversion to Biosimilar Rituximab-pvvr in Diffuse Large B-Cell Lymphoma in Medicare

    Jul 1, 2025, 00:00

  • P17 Health Inequality Aversion in the United States and Americans' Views on Health Inequality

    Jul 1, 2025, 00:00

  • RWD12 Patient-Reported Symptoms and Quality of Life: A Real-World Survey of Patients With Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • RWD143 Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data

    Jul 1, 2025, 00:00

  • EE399 Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • HTA67 Developing a Selection Framework for Comparator in HTA-Based Inclusion in China's National Reimbursement Drug List

    Jul 1, 2025, 00:00

  • PCR233 Physician, Patient and Caregiver Concordance in a Real-World US Generalized Myasthenia Gravis Population

    Jul 1, 2025, 00:00

  • PCR2 Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America

    Jul 1, 2025, 00:00

  • CO53 Comorbidity Burden Among Patients with Bullous Pemphigoid in the US Medicare Population

    Jul 1, 2025, 00:00

  • PT8 Time-Driven Activity-Based Costing in Healthcare: Should We Adjust for Inflation or Reapply the Method?

    Jul 1, 2025, 00:00

  • HPR106 Regional Differences in IVF Utilization Rates in Hungary in the Last Decade

    Jul 1, 2025, 00:00

  • PCR83 Treatment Preferences Related to Long-Acting Injectable Buprenorphine Among Patients With Opioid Use Disorder in Australia, Finland, Germany, and Italy

    Jul 1, 2025, 00:00

  • HPR16 Emerging Trends in List Price Adjustment Strategies Following Implementation of the Inflation Reduction Act

    Jul 1, 2025, 00:00

  • PT20 Estimating the Cost at which GLP-1 RAs Would become Cost-Effective for Multimorbid Type 2 Diabetes Patients in Canada

    Jul 1, 2025, 00:00

  • SA10 Improving the Face Validity and Clinical Relevance of a Cancer Epidemiology Microsimulation Model Using a Novel Advisory Group Approach

    Jul 1, 2025, 00:00

  • MSR156 Examining Factors Contributing to Age of Late-Onset Autoimmune Disease in U.S. Adults Using Hierarchical Clustering Mechanisms

    Jul 1, 2025, 00:00

  • EE460 Impact of Newborn Screening for Duchenne Muscular Dystrophy: A Model-Based Analysis

    Jul 1, 2025, 00:00

  • PCR159 Measurement of Short-Term Functional Outcome Using Modified Rankin Scale in Patients With Acute Ischaemic Stroke

    Jul 1, 2025, 00:00

  • MSR78 Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia

    Jul 1, 2025, 00:00

  • EE304 A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective

    Jul 1, 2025, 00:00

  • EPH44 Changes in Outpatient Visits in a Medicaid Population in the Face of Physician Shortages

    Jul 1, 2025, 00:00

  • PT22 Payer Archetypes and Decision-Making in the United States (US): A framework for Generalised Cost-Effectiveness Analysis (GCEA) Value Elements to Optimize Patient Access and Equity

    Jul 1, 2025, 00:00

  • MSR35 Training and Validation Methods of Artificial Intelligence Tools For Automated Systematic Reviews In Pharmacoepidemiology and Health Technology Assessment: A Systematic Review

    Jul 1, 2025, 00:00

  • RWD30 Assessing and Comparing Inpatient Hospitalization Outcomes for COPD in the United States and OECD Countries

    Jul 1, 2025, 00:00

  • EPH18 Estimating Lung Cancer Screening Utilization in the US Using the 2023 Behavioral Risk Factor Surveillance System Data

    Jul 1, 2025, 00:00

  • P61 Implementation of the IRA: Evolving Perspectives from US Stakeholders

    Jul 1, 2025, 00:00

  • PCR126 Balancing Vulnerability and Freedom: Perspectives on HIV Cure-Related Trials With Analytical Treatment Interruption Among People With HIV and Healthcare Practitioners in the United States

    Jul 1, 2025, 00:00

  • RWD135 Retrospective Databases in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research

    Jul 1, 2025, 00:00

  • MSR54 Leveraging Artificial Intelligence for Thematic Analysis of Qualitative Transcripts: A Feasibility Study in Insurance Payer Interviews

    Jul 1, 2025, 00:00

  • P28 The Use of Artificial Intelligence in the Development of Economic Models

    Jul 1, 2025, 00:00

  • RWD85 Short- and Longer-Term Healthcare Resource Utilization and Related Costs of Stroke in the Brazilian Private Market from 2019 to 2023

    Jul 1, 2025, 00:00

  • HSD15 Hypertrophic Scar Severity and Clinical Management in the Real-World Dermatology Setting

    Jul 1, 2025, 00:00

  • PCR178 Qualitative Insights on Meaningful Change in Symptoms and Impacts for Patients With Alpha-1 Antitrypsin Deficiency

    Jul 1, 2025, 00:00

  • PT38 Assessing the Impact of Digital Ecosystem Engagement on Outcomes in Sickle Cell Disease (SCD) Patients

    Jul 1, 2025, 00:00

  • RWD50 Real-World Healthcare Resource Utilization and Related Costs Associated with Ovarian Cancer in the Brazilian Private Market

    Jul 1, 2025, 00:00

  • EE345 Assessing Health-Related Quality of Life Using the EQ-5D-5L Among Hong Kong Adult Population: The Role of Lifestyle Behaviours

    Jul 1, 2025, 00:00

  • EE512 How HTA Should Consider the Global Value of Health Products to Support Public Decision?

    Jul 1, 2025, 00:00

  • HSD58 Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease

    Jul 1, 2025, 00:00

  • EE300 Ferric Derisomaltose for the Treatment of Iron Deficiency Anemia: A Real-World Evidence Study

    Jul 1, 2025, 00:00

  • HSD64 Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice

    Jul 1, 2025, 00:00

  • EE207 Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease

    Jul 1, 2025, 00:00

  • P34 Are Pediatric Trials Including More Patient-Centered Outcomes?

    Jul 1, 2025, 00:00

  • EE521 Generalized Cost-Effectiveness Analysis with Dynamic Prevalence for Improving Health Equity Among Rare Diseases

    Jul 1, 2025, 00:00

  • PCR28 Analysis of the Quality of Life of Patients Undergoing Hip Replacement Surgery Using the SF-36 Questionnaire

    Jul 1, 2025, 00:00

  • PCR182 Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients With C1 Inhibitor Deficiency (Type I/II) and =8 Attacks Per Month

    Jul 1, 2025, 00:00

  • MSR139 Application of Generative Artificial Intelligence for Extracting Structured Data from Unstructured Bladder Cancer Pathology Reports

    Jul 1, 2025, 00:00

  • PCR197 Impact of Cirrhosis on Health-Related Quality of Life and Activity Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada

    Jul 1, 2025, 00:00

  • HPR122 Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts

    Jul 1, 2025, 00:00

  • EE450 National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States

    Jul 1, 2025, 00:00

  • CO72 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Experienced Patients with T2D

    Jul 1, 2025, 00:00

  • HTA17 Are There Intersections in Evidence Requirements for Health Technology Assessment Agencies across North America, Europe and the Asia-Pacific?

    Jul 1, 2025, 00:00

  • MSR60 From AI to Experts: Understanding Pre-Election Inflation Narratives on Social Media via Sentiment and Topic Analysis

    Jul 1, 2025, 00:00

  • HSD89 Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE501 Cost-Effectiveness Analysis of Screening for Cervical Lesion and Diagnosis and Treatment of Cervical Cancer In Nigeria

    Jul 1, 2025, 00:00

  • MT34 Effectiveness of Digital Care Platforms for Cancer Patients: A Systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • MSR76 A Flexible Dynamic Transmission Model Framework for Evaluating Tuberculosis Treatments: Methodological Challenges and Applications

    Jul 1, 2025, 00:00

  • EE295 Modeling the Potential Health Benefits of Improving Nutrition in Australian Indigenous Populations

    Jul 1, 2025, 00:00

  • CO30 The Relationship Between Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma: A Meta-Regression of Clinical Trial Data

    Jul 1, 2025, 00:00

  • EPH92 Transfusion Needs For Patients With Myelofibrosis In Latin America

    Jul 1, 2025, 00:00

  • EE390 Real-World Healthcare Resource Utilization (HCRU) and Economic Burden Among Patients With High-Risk Carcinoma-In-Situ (CIS) Non-Muscle Invasive Bladder Cancer (NMIBC) Using a Large Medicare Dataset

    Jul 1, 2025, 00:00

  • MT11 How Does it Stack Up? User Comparison of the Ambu aScope 5 Uretero Against Reusable Ureteroscope Platforms

    Jul 1, 2025, 00:00

  • OP2 A Descriptive Analysis of Key Findings From the 2024-2025 ISPOR Student Interest Survey

    Jul 1, 2025, 00:00

  • EE279 Economic Burden of Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP): A Large United States (US) Nationwide Claims Analysis

    Jul 1, 2025, 00:00

  • EE334 Economic Evaluation of Transient Elastography for Significant Fibrosis Detection in Patients With Diabetes Mellitus in Thailand

    Jul 1, 2025, 00:00

  • MT9 Assessment of Artificial Intelligence-Enabled Health Technologies: Our Initial Experience at Canada's Drug Agency

    Jul 1, 2025, 00:00

  • HTA5 Health Technology Assessment Evidence Requirements for Companion Diagnostics Associated with Targeted Therapies in Oncology

    Jul 1, 2025, 00:00

  • PT42 Designing Value-Based Dental Insuran A Multicriteria Decision Analysis

    Jul 1, 2025, 00:00

  • RWD129 type 2 Inflammation and Exacerbator Profiles in COPD Patients: Real-World Data From a Brazilian Specialized Center

    Jul 1, 2025, 00:00

  • MSR15 Leveraging AI/Technology in Survey Design, Deployment, and Analysis

    Jul 1, 2025, 00:00

  • HSD28 Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)

    Jul 1, 2025, 00:00

  • HTA85 Developing a Value Assessment Framework for Modified New Drugs In China

    Jul 1, 2025, 00:00

  • EE293 A Comparative Assessment of ICER-Sponsored Versus Pharma-Sponsored Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • RWD107 Analysis of Antibody-Drug Conjugate Usage in Patients Undergoing Circulating Tumor DNA Testing

    Jul 1, 2025, 00:00

  • MSR84 Data Extraction in Literature Reviews Using an Artificial Intelligence Model: Prompt Development and Testing

    Jul 1, 2025, 00:00

  • EPH151 Depression Literacy in the Middle East and North Africa: A Scoping Review

    Jul 1, 2025, 00:00

  • PCR207 The Effect of Public Health Awareness Campaigns on Prostate Cancer-Related Online Information-Seeking Behavior: A Hungarian Experience

    Jul 1, 2025, 00:00

  • P54 Impact of Medicaid Enrollment Provisions on Postpartum Coverage and Resource Use in Three US States

    Jul 1, 2025, 00:00

  • MSR91 Reliability of Insurance Claims to Categorize Obesity in Patients with Obstructive Sleep Apnea

    Jul 1, 2025, 00:00

  • EE493 Cost Effectiveness of Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in China

    Jul 1, 2025, 00:00

  • MSR130 Using Real-World Data and Machine Learning to Identify Patients at Highest Risk for Hospitalization Following Respiratory Syncytial Virus Infection

    Jul 1, 2025, 00:00

  • HPR97 The Social Distribution of Quality Adjusted Life Expectancy (QALE) Among Deprivation Subgroups in China

    Jul 1, 2025, 00:00

  • PCR16 Integrating Patient-Reported Outcomes in Clinical Care: Opportunities and Roadblocks from the Clinician Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • P60 Feasibility of Replicating a Published Health Economic Model From an ICER Report Using Generative AI

    Jul 1, 2025, 00:00

  • EE253 Evaluation of Real-World Total Healthcare Costs Difference Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Breast Cancer Patients

    Jul 1, 2025, 00:00

  • PCR86 Health utilities of patients with multidrug-resistant tuberculosis and its influencing factors: A cross-sectional study based on EQ-5D-5L in China

    Jul 1, 2025, 00:00

  • EPH168 Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses

    Jul 1, 2025, 00:00

  • RWD145 Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States

    Jul 1, 2025, 00:00

  • HSD61 Impact of Using Telehealth in Primary Care on Healthcare Resource Utilization, Costs, and Medication Adherence in Diabetic Patients

    Jul 1, 2025, 00:00

  • MSR152 A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review

    Jul 1, 2025, 00:00

  • CO61 Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis

    Jul 1, 2025, 00:00

  • RWD124 Healthcare Resource Utilization for Medicare Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and Exacerbations Coinfected with Pseudomonas aeruginosa

    Jul 1, 2025, 00:00

  • MSR30 Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis

    Jul 1, 2025, 00:00

  • MSR103 Regularized MAIC As a Modern Solution for Indirect Treatment Comparison Challenges

    Jul 1, 2025, 00:00

  • PCR200 Exploring the Impact of Exercise Variability of Mental Health: Results From the 2024 US National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • EE411 Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder

    Jul 1, 2025, 00:00

  • PCR12 Hemolytic Disease of the Fetus and Newborn (HDFN): A Mixed-Methods Preference Study

    Jul 1, 2025, 00:00

  • EE446 The Blinded Economic Impact of Chemotherapy: How Adverse Effects Affect Costs During Bladder Oncology Treatments

    Jul 1, 2025, 00:00

  • HPR6 Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years

    Jul 1, 2025, 00:00

  • PT12 Large-Language Models to Complement and Augment Literature Review: Hi! How Can I Help You?

    Jul 1, 2025, 00:00

  • HSD48 Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example

    Jul 1, 2025, 00:00

  • HPR87 Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies

    Jul 1, 2025, 00:00

  • HTA27 How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?

    Jul 1, 2025, 00:00

  • Table of Contents

    Jul 1, 2025, 00:00

  • HSD35 Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • EPH34 Systematic Literature Review on the Economic Burden of Myopia

    Jul 1, 2025, 00:00

  • PCR18 Comparative Analysis of Smartphone Application and Web-based Electronic Clinical Outcome Assessment (eCOA) Modalities

    Jul 1, 2025, 00:00

  • EE478 Healthcare Resource Utilization Among Fabry Disease Patients in the U.S.: Insightes From a Real-World Retrospective Study

    Jul 1, 2025, 00:00

  • PCR95 State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials

    Jul 1, 2025, 00:00

  • PT36 Psychometric Evidence Supporting the Use of the EQ-5D in Long COVID: A Systematic Review

    Jul 1, 2025, 00:00

  • EE526 Impact of Recurrence Modelling on Cost-Effectiveness of New Treatments for Early Cancers

    Jul 1, 2025, 00:00

  • RWD137 Real-World Treatment Patterns of First-Line (1L) Ibrutinib in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL): Insights into Therapy Interruptions, Discontinuation and Next Treatment

    Jul 1, 2025, 00:00

  • RWD141 Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes

    Jul 1, 2025, 00:00

  • PT4 A Systematic Review on Economic Evaluations of Comparisons Between CAR-T Therapies in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Jul 1, 2025, 00:00

  • EE263 Population-Level Impact of Emicizumab for Hemophilia A Patients in Six Latin American (LATAM) Countries: A 25-Year Model

    Jul 1, 2025, 00:00

  • HPR119 Geographical and Temporal Variations in Availability of National Price Negotiated Novel Anticancer Drugs: A Spatial Statistical Study Based on Two Cross-Sectional Datasets in China

    Jul 1, 2025, 00:00

  • HSD77 Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer

    Jul 1, 2025, 00:00

  • MT8 Can Robotics Narrow the Access Disparities in Minimally Invasive Surgery?

    Jul 1, 2025, 00:00

  • PCR109 Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance

    Jul 1, 2025, 00:00

  • EE303 The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease

    Jul 1, 2025, 00:00

  • HSD17 Co-Design of a Discrete Choice Experiment for Revascularization Decisions in Complex Coronary Heart Disease: Importance of Patient Perspectives

    Jul 1, 2025, 00:00

  • EE310 Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States

    Jul 1, 2025, 00:00

  • EE287 Cost Effectiveness of Pembrolizumab in Combination with Chemotherapy for the Treatment of Patients with Locally Advanced or Metastatic HER2-Negative Gastric or Gastroesophageal Cancer in Mexico

    Jul 1, 2025, 00:00

  • RWD95 Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US

    Jul 1, 2025, 00:00

  • RWD68 AUVI-Q vs. Other Epinephrine Auto-Injector Prescription Was Associated With Reduced Inpatient Hospitalizations for Anaphylaxis in a US Retrospective Commercial Claims Analysis

    Jul 1, 2025, 00:00

  • RWD164 ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access

    Jul 1, 2025, 00:00

  • HSD78 Early Breast Cancer in the US and Germany: A Comparison of Real-world Screening and Treatment

    Jul 1, 2025, 00:00

  • RWD117 Concordance of ER and HER2 Status by Claims-Based Algorithm and Large Language Models (LLM) Abstracted Clinical Notes in Patients With Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • RWD34 Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities

    Jul 1, 2025, 00:00

  • HPR143 Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain

    Jul 1, 2025, 00:00

  • MSR102 Validation Evidence of Self-Reported Measures for Healthcare Resource Utilization in Adult Populations: A Systematic Review

    Jul 1, 2025, 00:00

  • EE442 Assessing the Relationship Between Pruritus and Work Productivity Among Individuals With PBC and Pruritus: Results From the ITCH-E Study

    Jul 1, 2025, 00:00

  • CO55 A Retrospective Real-World Data Analysis of Pregnancy Outcomes Among Women with a History of Hysteroscopic Intrauterine Adhesiolysis (HA), Other Intrauterine Surgery (IUs), or no Prior IUs

    Jul 1, 2025, 00:00

  • PCR248 Adherence to Anti-Tubercular Medications in the United States: Insights from MarketScan Data (2016-2021)

    Jul 1, 2025, 00:00

  • HSD12 Predictors of Therapeutic Duplication Among Older Adults in the National Social Health in Aging Project

    Jul 1, 2025, 00:00

  • RWD98 Association of Combined Opioid and Marijuana Use with Major Depressive Disorder among Adults with Chronic Conditions in the United States (US)

    Jul 1, 2025, 00:00

  • HSD2 Cognitive Impairment at Initial Diagnosis of Alzheimer’s Disease: Patient Characteristics and Treatments in the Real-World Setting

    Jul 1, 2025, 00:00

  • PCR201 Comparison of Rare Disease Patient and Caregiver Disease Burden in Terms of Economic, Social, and Interpersonal Impact and Impact on Quality Of Life: Results From an International Survey

    Jul 1, 2025, 00:00

  • PCR243 Developing a Checklist for Patient Engagement in Rare Disease Value Research

    Jul 1, 2025, 00:00
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »